Skip to content

Using GLP-1s

What is suppression, satiation, and satiety on a GLP-1?

GLP-1 medications change appetite in three related but distinct ways: suppression, satiation, and satiety. What each means and what to expect.

By the glp1.how editorial teamReviewed 3 min read

Evidence-backed

"I'm just not hungry the way I used to be" is one of the first things people say on a GLP-1. That one sentence actually describes three different things happening at once: appetite suppression, satiation, and satiety. Each changes your relationship with food at a different point in the eating process. Knowing which is which makes it easier to tell what's normal, what to mention to your provider, and how to eat well while it's happening.

Suppression, satiation, and satiety: what's the difference?

Appetite suppression

Appetite suppression is a reduction in the drive to eat in the first place. GLP-1 receptor agonists act on areas of the brain (including the hypothalamus and brainstem) that regulate hunger, dampening the hunger and reward cues that normally prompt you to seek out food. Mouse studies have mapped a hypothalamic circuit through which liraglutide quiets the hunger-driving AgRP neurons (Webster et al., Nature Metabolism, 2024, DOI (external link)), and shown that semaglutide dampens the dopamine neurons that drive eating for pleasure, an effect that can weaken with repeated dosing (Zhu et al., Science, 2025, DOI (external link)).

In daily life this looks like lower interest in food overall, fewer intrusive thoughts about eating, less grazing between meals, and sometimes having to remind yourself to eat instead of waiting to feel hungry.

Satiation

Satiation is the fullness that builds during a meal and tells you to stop eating. On a GLP-1, it arrives earlier in the meal. The drugs also slow the rate at which food leaves the stomach, but that turns out to be a minor part of the story. A 2026 analysis of a liraglutide trial found gastric emptying accounted for only 4–6% of the differences in appetite measures, and the authors concluded it appears to play little direct role in the drug's appetite suppression (Friedman et al., Obesity, 2026, DOI (external link)). The study didn't test what does the rest. Researchers analyzing the STEP semaglutide trials attribute the appetite effect mainly to the drug's direct and indirect actions on the brain, particularly the hypothalamus and hindbrain (Wharton et al., Diabetes, Obesity and Metabolism, 2021, DOI (external link)).

You'll notice it as feeling full after a few bites, needing to eat more slowly, or finding that a plate that used to be a normal portion is now too much. Eating too quickly or too much despite this cue is a common cause of nausea or discomfort on GLP-1s.

Satiety

Satiety is the fullness that lasts between meals, the reason you don't feel hungry again for hours after eating. GLP-1 medications extend this window through their effects on brain satiety circuits, with slower digestion possibly adding a little, so the feeling of fullness carries well past the meal.

This shows up as longer stretches without thinking about food, skipping snacks without noticing, and sometimes needing a reminder or schedule to make sure you're still eating enough across the day.

Why the distinction matters

These three effects work together to reduce overall food intake, but they show up at different points in the eating process:

MechanismWhen it actsWhat it affects
SuppressionBefore eatingDesire/drive to eat
SatiationDuring a mealWhen you stop eating
SatietyAfter a mealHow long until you're hungry again

Knowing which one you're experiencing helps you troubleshoot. If you're consistently uncomfortable during meals, that points to satiation, and eating more slowly or choosing smaller, more frequent portions may help. If you're going long stretches without eating at all, that's satiety, and it's worth watching so you don't under-eat protein, fiber, or key nutrients.

When to talk to your provider

Reach out to your care team if:

  • You're going a full day or more with little to no appetite or intake
  • You're losing weight faster than expected or feel weak/fatigued
  • Fullness during meals comes with persistent nausea, vomiting, or pain
  • You're finding it hard to eat enough protein or stay hydrated

These appetite changes are how GLP-1 medications affect weight, but the goal is sustainable, adequate nutrition, not eating as little as possible.

Study findings above are attributed to their authors and were located via PubMed.

This is general education, not medical advice. If these appetite changes leave you unable to eat or drink enough, talk to your care team about adjusting your plan.

satietysatiationappetite-suppressionappetitemechanismside-effects

Common questions

Questions people often ask about this topic.

  • What's the difference between suppression, satiation, and satiety?

    They act at different points in the eating process. Appetite suppression reduces the drive to eat in the first place, satiation is the fullness that builds during a meal and tells you to stop, and satiety is the fullness that lasts between meals so you don't get hungry again for hours. GLP-1 medications affect all three at once, which is why "I'm just not hungry the way I used to be" really describes three different things.

  • Why do I feel full after only a few bites on a GLP-1?

    That's satiation: fullness arrives earlier in the meal. GLP-1 medications can slow the rate at which food leaves the stomach, but research suggests that explains only a small part of the effect; in one liraglutide trial analysis, gastric emptying accounted for just 4–6% of the differences in appetite measures. The drugs' effects on the brain are thought to do most of the work. Eating too quickly or too much despite the cue is a common cause of nausea or discomfort, so eating more slowly or choosing smaller portions can help.

  • Is it normal to forget to eat on a GLP-1?

    Yes. Going long stretches without thinking about food is a common satiety effect: the medication acts on brain satiety circuits, so fullness carries well past the meal. Some people need a reminder or schedule to make sure they're still eating enough across the day, particularly enough protein, fiber, and key nutrients.

  • When should appetite changes on a GLP-1 prompt a call to my provider?

    Reach out if you're going a full day or more with little to no appetite or intake, losing weight faster than expected or feeling weak or fatigued, having fullness together with persistent nausea, vomiting, or pain, or finding it hard to eat enough protein or stay hydrated. These appetite changes are how the medication works, but the goal is sustainable, adequate nutrition, not eating as little as possible.

Evidence

The sources behind this article, labeled by type and strength.

Supporting6

Revision history

Updated 5 times since Sep 2, 2026 · show changes
  1. v6

    Evidence sources 5 → 6

  2. v5

    Common questions revised

  3. v4

    Summary rewritten; Body revised

  4. v3

    Common questions revised

  5. v2

    Body revised

  6. v1

    Change tracking began

Community content

Videos shared by the community. Informational, not endorsements.

Related guides

Related terms

  • GLP-1 · A gut hormone (glucagon-like peptide-1) that stimulates insulin release, slows digestion, and reduces appetite; the target of drugs like semaglutide and liraglutide.
  • Appetite suppression · A reduction in the drive or desire to eat, distinct from the fullness felt during or after a meal.
  • Satiation · The feeling of fullness that builds during a meal and signals you to stop eating.
  • Satiety · The sense of fullness that persists between meals, delaying the return of hunger.
  • Liraglutide · A first-generation GLP-1 receptor agonist taken as a daily injection, sold as Victoza for type 2 diabetes and Saxenda for weight management, and now also as a US generic.
  • Semaglutide · A GLP-1 receptor agonist medication made by Novo Nordisk, sold under the brand names Ozempic (type 2 diabetes) and Wegovy (weight management), each as an injection or a pill.
  • Gastric emptying · The rate at which the stomach passes its contents into the small intestine, which GLP-1 medications slow down.

Was this helpful?

Improve this page